Biotech news for Sunday, May 17, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
Earnings Call Insights: Autolus Therapeutics (AUTL) Q1 2026 Management View "We had a very good first quarter, and we see nice traction building both in the U.S. and obviously, in our early launch in the U.K. as well." (CEO & Director Christian Itin)
Earnings Call Insights: Cibus, Inc. (CBUS) Q1 2026 Management View “If I had to distill our message today into a single word, it would be execution,” said (Co-Founder, Interim CEO, President, COO & Director Peter Beetham), adding, “We raised significant ca…
Earnings Call Insights: AVITA Medical (RCEL) Q1 2026 Management View “Revenue was approximately $19.3 million, up 4% year-over-year and approximately 10% sequentially,” and “we are reaffirming full year guidance of $80 million to $85 million,” as AVITA “begun…